» Articles » PMID: 16696653

Do Major Species Concepts Support One, Two or More Species Within Cryptococcus Neoformans?

Overview
Journal FEMS Yeast Res
Specialty Microbiology
Date 2006 May 16
PMID 16696653
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptococcus neoformans, the agent of cryptococcosis, had been considered a homogeneous species until 1949 when the existence of four serotypes was revealed based on the antigenic properties of its polysaccharide capsule. Such heterogeneity of the species, however, remained obscure until the two morphologically distinct teleomorphs of C. neoformans were discovered during the mid 1970s. The teleomorph Filobasidiella neoformans was found to be produced by strains of serotype A and D, and Filobasidiella bacillispora was found to be produced by strains of serotype B and C. Ensuing studies revealed numerous differences between the anamorphs of the two Filobasidiella species with regard to their ecology, epidemiology, pathobiology, biochemistry and genetics. At present, the etiologic agent of cryptococcosis is classified into two species, C. neoformans (serotypes A and D) and Cryptococcus gattii (serotypes B and C). Intraspecific genetic diversity has also been revealed as more genotyping methods have been applied for each serotype. As a result, the number of scientifically valid species within C. neoformans has become a controversial issue because of the differing opinions among taxonomists as to the appropriate definition of a species. There are three major species concepts that govern classification of organisms: phenetic (morphologic, phenotypic), biologic (interbreeding) and cladistic (evolutionary, phylogenetic). Classification of the two C. neoformans species has been based on the phenetic as well as the biologic species concept, which is also supported by the cladistic species concept. In this paper, we review and attest to the validity of the current two-species system in light of the three major species concepts.

Citing Articles

Quantitative MRI of a Cerebral Cryptococcoma Mouse Model for In Vivo Distinction between Different Cryptococcal Molecular Types.

Musetta L, Helsper S, Roosen L, Maes D, Croitor Sava A, Vanherp L J Fungi (Basel). 2024; 10(8).

PMID: 39194918 PMC: 11355240. DOI: 10.3390/jof10080593.


Determination of Ploidy Levels and Nuclear DNA Content in by Flow Cytometry: Drawbacks with Variability.

Chang Y, Davis M, Kwon-Chung K J Fungi (Basel). 2024; 10(4).

PMID: 38667967 PMC: 11051530. DOI: 10.3390/jof10040296.


The structure of a polysaccharide motif recognized by protective antibodies: A combined NMR and MD study.

Hargett A, Azurmendi H, Crawford C, Wear M, Oscarson S, Casadevall A Proc Natl Acad Sci U S A. 2024; 121(7):e2315733121.

PMID: 38330012 PMC: 10873606. DOI: 10.1073/pnas.2315733121.


The structure of a polysaccharide motif recognized by protective antibodies: A combined NMR and MD study.

Hargett A, Azurmendi H, Crawford C, Wear M, Oscarson S, Casadevall A bioRxiv. 2023; .

PMID: 37732210 PMC: 10508755. DOI: 10.1101/2023.09.06.556507.


Comparative analysis of diagnostic methods for the detection of Cryptococcus neoformans meningitis.

Dantas K, Santos de Freitas-Xavier R, Spina Lombardi S, Junior A, da Silva M, Criado P PLoS Negl Trop Dis. 2023; 17(3):e0011140.

PMID: 36877731 PMC: 10019727. DOI: 10.1371/journal.pntd.0011140.